batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. Against the odds biopharma throws all it can at CD47 26 September 2023 AbbVie ends its third oncology deal in two weeks 26 September 2023 Roche slips further behind in perioperative lung cancer 25 September 2023 Yet again Lenvima fails to Leap 22 September 2023 Olema follows Pfizer into KAT6 21 September 2023 Roche enters phase 3 in first-line lymphoma with Columvi 21 September 2023 Bristol joins the BCMA first-line multiple myeloma race 21 September 2023 Seeking a better PRMT5 inhibitor 20 September 2023 Load More